603351 Nanjing Well Pharmaceutical Group
- 24.50
- -0.06-0.24%
Nanjing Well Pharmaceutical Group News
Well Pharmaceutical: Weil Pharmaceutical\'s announcement on the company\'s main operating data for the third quarter of 2024
Announcement of Nanjing Well Pharmaceutical Group's main business data for the first half of 2024.
Announcement of the resolution of the 9th meeting of the 3rd supervisory board of Nanjing Well Pharmaceutical Group.
Announcement Regarding Nanjing Well Pharmaceutical Group Holding a Half-Year Performance Presentation for 2024
Announcement of the resolution of the Ninth Meeting of the Third Board of Directors of Nanjing Well Pharmaceutical Group.
Well Pharmaceuticals 2023 Financial Statement Audit Report
Weil Pharmaceutical's 2023 Independent Director Debriefing Report (Guan Guofeng)
Well Pharmaceuticals 2023 Internal Control Audit Report
Special instructions on the use of non-operating capital and other related capital transactions by Well Pharmaceutical in 2023
Weil Pharmaceutical's announcement on holding the 2023 and first quarter 2024 results briefings
Weil Pharmaceutical's 2023 Independent Director Debriefing Report (Guan Yamei)
Weil Pharmaceutical's 2023 Independent Director Debriefing Report (Wei Ming)
Weil Pharmaceutical's 2023 Independent Director Debriefing Report (Zhang Can)
Weir Pharmaceutical's 2023 Independent Director Debriefing Report (Yang Yanwei)
Weill Pharmaceutical's 2023 Independent Director Debriefing Report (Jia Ru)
Will Pharmaceutical's 2023 Accounting Firm Performance Assessment Report
Special opinion of the board of directors of Weill Pharmaceuticals on the independence of independent directors
Announcement of Resolutions of the Eighth Meeting of the 3rd Supervisory Board of Weill Pharmaceuticals
Weill Pharmaceuticals Announcement on Expected Daily Sex-related Transactions in 2024
Announcement of Resolutions of the Eighth Meeting of the Third Board of Directors of Well Pharmaceuticals
No Data